CLGN CollPlant Biotechnologies Ltd.
Healthcare$0.41-2.67%ClosedMarket Cap: $5.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.90
P/S
2.20
EV/EBITDA
-0.20
DCF Value
$-2.77
FCF Yield
-186.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
26.3%
Operating Margin
-484.3%
Net Margin
-484.6%
ROE
-114.1%
ROA
-106.5%
ROIC
-128.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $60.0K | -580.0% | $-3.1M | $-3.2M | $— | — |
| FY null | $2.4M | 26.3% | $-11.5M | $-11.5M | $— | — |
| Q3 null | $77.0K | -539.0% | $-3.5M | $-3.5M | $— | — |
| Q2 null | $179.0K | -131.8% | $-3.2M | $-3.3M | $— | — |
| Q1 null | $2.1M | 79.0% | $-1.6M | $-1.5M | $— | — |
| Q4 null | $164.0K | -213.4% | $-4.0M | $-3.9M | $— | — |
| FY null | $515.0K | -417.1% | $-17.3M | $-16.6M | $— | — |
| Q3 null | $4.0K | -13075.0% | $-4.5M | $-4.3M | $— | — |
| Q2 null | $249.0K | -220.1% | $-4.4M | $-4.2M | $— | — |
| Q1 null | $98.0K | -741.8% | $-4.3M | $-4.2M | $— | — |
| Q4 2023 | $299.0K | -253.5% | $-5.1M | $-4.7M | $-0.41 | — |
| FY null | $11.0M | 71.8% | $-7.5M | $-7.0M | $— | — |